aibot88 Cybersecurity Risk Assessor Skill
Purpose
The Cybersecurity Risk Assessor Skill evaluates cybersecurity risks for medical devices per FDA guidance and IEC 81001-5-1, supporting threat modeling, vulnerability assessment, and security control implementation.
Capabilities
- Threat modeling (STRIDE methodology)
- Vulnerability assessment
- SBOM (Software Bill of Materials) generation
- Security control identification
- Penetration testing planning
- Cybersecurity documentation for FDA submissions
- Attack surface analysis
- Security architecture review
- Coordinated vulnerability disclosure planning
- Postmarket cybersecurity management
- Patch management planning
Usage Guidelines
When to Use
- Assessing device cybersecurity risks
- Planning penetration testing
- Preparing FDA cybersecurity submissions
- Managing software dependencies
Prerequisites
- Software architecture documented
- Network connectivity defined
- Data flows identified
- Third-party components cataloged
Best Practices
- Integrate cybersecurity from design inception
- Maintain current SBOM
- Plan for security updates throughout lifecycle
- Establish vulnerability disclosure process
Process Integration
This skill integrates with the following processes:
- Software Development Lifecycle (IEC 62304)
- Medical Device Risk Management (ISO 14971)
- 510(k) Premarket Submission Preparation
- Post-Market Surveillance System Implementation
Dependencies
- FDA Cybersecurity guidance
- IEC 81001-5-1 standard
- SBOM tools (CycloneDX, SPDX)
- Vulnerability databases (NVD, CVE)
- Threat modeling frameworks
Configuration
cybersecurity-risk-assessor:
threat-methodologies:
- STRIDE
- PASTA
- attack-trees
sbom-formats:
- CycloneDX
- SPDX
security-tiers:
- Tier-1-higher
- Tier-2-standard
control-frameworks:
- NIST-CSF
- IEC-62443
Output Artifacts
- Threat models
- Vulnerability assessments
- SBOM documents
- Security architecture documents
- Penetration test plans
- FDA cybersecurity submissions
- Security control matrices
- Patch management plans
Quality Criteria
- All threat vectors identified
- Vulnerabilities assessed with CVSS scores
- SBOM is complete and current
- Security controls address identified risks
- Documentation meets FDA requirements
- Postmarket security plan established